GlassScriptPhysician profile
Jamie R Bartlett
NPI 1467856773
$4,187.15
in general payments reported to CMS, 2019-2025
35 companies · $1,174 in 2025
The $1,174 reported for 2025 was more than what 87% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $519 · 2022: $644 · 2023: $776 · 2024: $1,073 · 2025: $1,174.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,978 · Education: $45.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,978.26 |
| Education | $45.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $997.75 | 2021-2025 | |
| Lilly USA, LLC | $639.83 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $343.14 | 2021-2025 | Rybelsus, Wegovy, Ozempic |
| Glaxosmithkline, LLC. | $334.58 | 2021-2025 | Arexvy, Shingrix, Trelegy Ellipta |
| Axsome Therapeutics, INC. | $225.80 | 2024-2025 | Auvelity |
| Takeda Pharmaceuticals U.S.A., INC. | $215.24 | 2021-2025 | Glassia, Trintellix, Gattex |
| Pfizer INC. | $137.29 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $129.22 | 2021-2025 | Breztri, Fasenra, Airsupra |
| Amgen INC. | $122.37 | 2021-2025 | Repatha, Otezla, Otezla |
| Exact Sciences Corporation | $121.24 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Abbott Laboratories | $90.05 | 2021-2025 | Freestyle Libre 3 |
| Phathom Pharmaceuticals, INC. | $82.03 | 2024-2025 | Voquezna |
| Mylan Specialty L.P. | $69.63 | 2021-2024 | Yupelri |
| Corium, LLC | $62.59 | 2023-2025 | Azstarys |
| Bayer Healthcare Pharmaceuticals INC. | $60.66 | 2022-2025 |
Show all 35 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jamie Bartlett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.